Table 1.
Patient #1 | Patient #2 | |
---|---|---|
BASELINE | ||
Age | 70 | 64 |
Gender | Female | Male |
Etiology of Heart Failure | Non-Ischemic | Ischemic |
VT Characteristics | Monomorphic at >188 bpm | Monomorphic at 135 bpm |
Type of Surgical Ablation | Epicardial Endocardial | Epicardial Endocardial |
LVAD | HeartMate II | HeartMate II |
LVAD Indication | Destination Therapy | Bridge to Transplant |
POST-LVAD | ||
Antiarrhythmic | Amiodarone | Amiodarone Mexiletine |
Anticoagulation | Heparin Warfarina | Heparin Warfarina |
Aspirin | 81 mg | 81 mg |
Peak LDHb | 2086 U/L | 1368 U/L |
Further VT | No | No |
Thrombus Confirmed from Explanted LVAD | Yes | Yes |
aInternational normalized ratio goal 2.0-3.0
bNormal lab value 124–271 U/L
bpm beats per minute, LDH lactate dehydrogenase, LVAD left ventricular assist device, VT ventricular tachycardia